Project Grant R01DK147932
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $753,479 on June 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the clinical and cost-effectiveness of a multifaceted population health management intervention that facilitates primary care physician and nephrologist co-management for chronic kidney disease care. The project, titled "Enhancing PCP-Nephrologist...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $988,397 on September 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to pilot-test ONWARD, an intervention addressing health-related social needs in adolescents and young adults with type 2 diabetes. The project will conduct a randomized pilot 2×2 factorial trial with 52 adolescents and young adults and their caregivers to evaluate...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $380,808 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and test a pharmacist-led population health management intervention designed to optimize guideline-recommended medication therapy for individuals with chronic kidney disease. The research addresses medication therapy problems in nephrology care, where up to...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $812,862 on June 12, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify novel biomarkers of early progressive kidney function decline in type 1 diabetes. The research will use urinary and plasma peptidomics—analysis of synthesized peptides and protein degradation fragments—to discover prognostic markers that predict diabetic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $176,671 on February 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a K23 Career Development Award for Dr. Vikram Raghu. The award funds Dr. Raghu's research career development focused on addressing disparities in pediatric intestinal failure, a rare chronic condition requiring daily parenteral nutrition infusions. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $114,000 to The Nemours Foundation on May 12, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop provider-focused dissemination strategies for evidence-based psychosocial care in Type 1 Diabetes. The project addresses the gap between evidence-based pediatric T1D psychosocial interventions and their adoption in clinical practice. Youth with Type 1 Diabetes...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Children's Hospital of Philadelphia Research Institute $1.868 million on June 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct integrative proteomics, metabolomics, and genomics analysis identifying mechanistic pathways of adverse outcomes in pediatric chronic kidney disease. The research leverages stored biosamples and existing data from over 1,100...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $160,575 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K01DK147658). The award funds a three-year study of Medicaid alternative payment model (APM) implementation and evidence-based practice adoption in federally qualified health centers (FQHCs) to improve diabetes outcomes. The research addresses how FQHCs, which...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Vanderbilt University Medical Center $158,158 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a research project examining guideline-concordant pediatric obesity care in outpatient pediatric clinics. The award funds Dr. Colin Orr's research using the Science, Technology, and Research (STAR) and PEDSnet clinical research networks to create a...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Children's Hospital of Philadelphia $356,000 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and pilot test PAC-IT (Partnering with Adolescents to Choose and Implement Technology in the Management of T1D), a parent- and youth-directed intervention designed to promote youth decision-making involvement in the selection and implementation of...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $735,900 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to research electronic consultation (eConsult) practices for pediatric obesity care. The award funds a five-year investigation (through May 31, 2031) into best practices for asynchronous subspecialty consultation in pediatric obesity management, with focus on Medicaid-insured children who face barriers accessing pediatric endocrinologists, gastroenterologists, cardiologists, nephrologists, and sleep medicine specialists. The project addresses a gap: Federal Medicaid authorization of eConsults in January 2023 prompted adoption across 22 states within 24 months, but state-level variation in authorization and use has created urgent questions about optimal eConsult deployment for youth with obesity and comorbidities including type 2 diabetes, steatotic liver disease, dyslipidemia, hypertension, and obstructive sleep apnea. Without evidence-based guidance, eConsults risk either underutilization (limiting health impact) or supply-induced overuse (increasing utilization without improving outcomes). The research will generate guidance for payers, health systems, and clinicians on eConsult implementation within the pediatric Medicaid population. Place of performance is Pittsburgh, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $735.9k | 9/1/26 |